CpG ODN (K3)—toll-like receptor 9 agonist—induces Th1-type immune response and enhances cytotoxic activity in advanced lung cancer patients: a phase I study
Background: Cytosine-phosphate-guanine oligodeoxynucleotide (CpG ODN) (K3)—a novel synthetic single-stranded DNA immune adjuvant for cancer immunotherapy—induces a potential Th1-type immune response against cancer cells. We conducted a phase I study of CpG ODN (K3) in patients with lung cancer to as...
Main Authors: | Hamaguchi, M. (Author), Hirata, H. (Author), Ishii, K.J (Author), Kida, H. (Author), Kimura, K. (Author), Kumanogoh, A. (Author), Kuroda, E. (Author), Manabe, Y. (Author), Miyake, K. (Author), Mizuno, Y. (Author), Nishida, S. (Author), Otsuka, T. (Author), Shibahara, T. (Author), Shiroyama, T. (Author), Takeda, Y. (Author), Temizoz, B. (Author), Yagita, M. (Author) |
---|---|
Format: | Article |
Language: | English |
Published: |
BioMed Central Ltd
2022
|
Subjects: | |
Online Access: | View Fulltext in Publisher |
Similar Items
-
Carbonate Apatite Nanoparticles Act as Potent Vaccine Adjuvant Delivery Vehicles by Enhancing Cytokine Production Induced by Encapsulated Cytosine-Phosphate-Guanine Oligodeoxynucleotides
by: Hideki Takahashi, et al.
Published: (2018-04-01) -
Immunostimulatory effects and delivery of oligodeoxynucleotides containing CpG motifs (CpG-ODN) in neonatal broiler chickens
by: Joze Taghavi Shirazi, Azita
Published: (2008) -
Preparation, characterization, and evaluation of chitosan-based nanoparticles as CpG ODN carriers
by: Febriana Catur Iswanti, et al.
Published: (2019-01-01) -
INFLUENCE OF CpG ODN 2006 OLIGODEOXYNUCLEOTIDE ON CYTOKINE PRODUCTION BY BLOOD CELLS OF HUMANS VACCINATED AGAINST PLAGUE
by: S. N. Klyueva, et al.
Published: (2015-01-01) -
Discovery of Cisplatin Binding to Thymine and Cytosine on a Single-Stranded Oligodeoxynucleotide by High Resolution FT-ICR Mass Spectrometry
by: Wenjuan Zeng, et al.
Published: (2019-05-01)